Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
The ultrasound energy reaches the layer below the patients skin, liquifying the fat and triggering albuminoid growth, so reducing or perhaps eliminating dimpling and loose skin appearance
Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2/slc7a11 Axis
Ensures deep and perfect hydration
Analysis of Glutathione Research Peptide behavior in laboratory redox and antioxidant pathway studies
Glutathione (410mg) A master antioxidant that helps reduce melanin production, promoting a whiter, more even complexion while protecting the skin from toxins and oxidative stress
